| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/20/1992 | EP0485476A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 05/20/1992 | EP0485458A1 Thioacylating reagents and intermediates, thiopeptides, and methods for preparing and using same. |
| 05/20/1992 | EP0485407A1 Proteins with tnf activity |
| 05/20/1992 | EP0485380A1 Immunological use of microwaves |
| 05/20/1992 | EP0476007A4 Catalytic antibodies |
| 05/20/1992 | EP0466811A4 Brassica linkage map |
| 05/20/1992 | EP0437556A4 Substitution analogues of magainin peptides |
| 05/20/1992 | EP0258404B1 Method of detecting antibody against htlv-iii |
| 05/20/1992 | EP0229110B1 Solubilization and oxidation of somatotropin from transformed microorganisms |
| 05/20/1992 | EP0209539B1 Homogeneous erythropoietin |
| 05/20/1992 | EP0131627B1 Specific cea-family antigens, antibodies specific thereto and their methods of use |
| 05/20/1992 | CN1061245A Bioassay for detention of b. burgdorferi |
| 05/20/1992 | CA2055685A1 Hiv protease inhibitors having polyether substituents |
| 05/19/1992 | US5115102 Variant proteins and polypeptides possessing enhanced affinity for immobilized-metal affinity matrices |
| 05/19/1992 | US5115100 Purification of hemoglobin and methemoglobin by bioselective elution |
| 05/19/1992 | US5115097 Synthetic peptide from the carboxy terminal of human Mn-superoxide dismutase |
| 05/19/1992 | US5115096 Amphiregulin: a bifunctional growth modulating glycoprotein |
| 05/19/1992 | US5114962 New amino acid esters, a process for their preparation, medicaments containing them, and the use thereof |
| 05/19/1992 | US5114927 Hypotensive agents and inhibiting renin |
| 05/19/1992 | US5114923 Recombinant techniques for production of novel natriuretic and vasodilator peptides |
| 05/19/1992 | US5114922 Animal extracts from leeches |
| 05/19/1992 | US5114921 Amphiphilic peptides and use thereof |
| 05/19/1992 | US5114918 Endothelin antagonistic cyclic pentapeptides |
| 05/19/1992 | US5114847 Fusion with cytoplasm from transformed cells; hybridomas |
| 05/19/1992 | US5114844 Immunoassay with a protein or antibody |
| 05/19/1992 | US5114843 Humoral hypercalcemic factor antagonists |
| 05/19/1992 | US5114842 Immunology, DNA and DNA sequences encoding genes |
| 05/19/1992 | US5114840 Method for determining the nucleotide sequence of a novel α5(IV) chain of human type IV collagen |
| 05/19/1992 | US5114713 P. falciparum cs-peptides as universal t-cell epitope |
| 05/19/1992 | US5114712 Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection |
| 05/19/1992 | US5114711 Covalently linked polypeptide cell modulators such as interferon-lymphotoxin conjugates |
| 05/19/1992 | US5114710 M-csf as a therapeutic agent for thrombocytopenia |
| 05/19/1992 | CA1301096C High yield protein production system |
| 05/19/1992 | CA1301095C Human che type proteins and their production |
| 05/19/1992 | CA1301094C Bacillus thuringiensis crystal protein gene toxin segment |
| 05/19/1992 | CA1301065C Polypeptidic composition useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antimerozoite antibodies |
| 05/18/1992 | CA2055635A1 Antiviral activity of the rep gene encoded by adenoassociated virus type 2 |
| 05/17/1992 | WO1992008792A2 Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5 |
| 05/17/1992 | WO1992008786A1 Human rotaviruses, vaccines and methods |
| 05/17/1992 | WO1992008490A1 Skin-associated lymphocytes and markers |
| 05/17/1992 | CA2096329A1 Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5 |
| 05/17/1992 | CA2096117A1 Skin-associated lymphocytes and markers |
| 05/16/1992 | WO1992008726A1 Rat thyrotropin receptor gene and uses thereof |
| 05/16/1992 | WO1992008709A1 Meta-substituted phenyl alanine derivatives |
| 05/16/1992 | CA2095013A1 Rat thyrotropin receptor gene and uses thereof |
| 05/16/1992 | CA2073776A1 Meta-substituted phenyl alanine derivatives |
| 05/16/1992 | CA2048078A1 Chemical modification of antibodies for creation of immunoconjugates |
| 05/15/1992 | WO1992008482A1 Compositions for reducing oxidative injury |
| 05/15/1992 | WO1992008481A1 Stabilized, potent grf analogs |
| 05/15/1992 | CA2096333A1 Compositions for reducing oxidative injury |
| 05/15/1992 | CA2095539A1 Diagnosis and treatment of multiple sclerosis |
| 05/15/1992 | CA2092906A1 Stabilized, potent grf analogs |
| 05/14/1992 | WO1992008485A1 Diagnostic testing for campylobacter jejuni or coli infection using antigens |
| 05/14/1992 | WO1992008131A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | WO1992007956A1 Process for amplifying nucleic acid |
| 05/14/1992 | WO1992007945A1 Cell type specific alteration of levels of gene products in neural cells |
| 05/14/1992 | WO1992007943A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | WO1992007942A1 Polypeptides involved in the expression of resistance to glycopeptidic antibiotics |
| 05/14/1992 | WO1992007941A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/14/1992 | WO1992007940A2 Bovine respiratory syncytial virus genes |
| 05/14/1992 | WO1992007939A2 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | WO1992007938A1 Cell growth inhibitors |
| 05/14/1992 | WO1992007937A1 Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides |
| 05/14/1992 | WO1992007935A1 Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions |
| 05/14/1992 | WO1992007877A1 Hair growth regulating composition comprising epithelium cell supernatant-derived growth factor |
| 05/14/1992 | WO1992007875A1 Cytolytic factor associated with effector cell plasma membranes |
| 05/14/1992 | WO1992007874A1 Pharmaceutically active proteins comprising an active protein and an integrinaffinity sequence |
| 05/14/1992 | WO1992007872A1 Tenascin related peptides |
| 05/14/1992 | WO1992007871A1 Peptide-based inhibitors of hiv replication |
| 05/14/1992 | WO1992007576A1 Protective four amino acid epitope against plasmodium vivax malaria |
| 05/14/1992 | WO1992007573A1 Genetic modification of endothelial cells |
| 05/14/1992 | WO1992007572A1 Agents and methods for binding to elam-1 |
| 05/14/1992 | WO1992002621A3 Allergens of alder pollen and applications thereof |
| 05/14/1992 | WO1992001718A3 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/1992 | WO1991018984A3 New antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi |
| 05/14/1992 | WO1991018911A3 Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof |
| 05/14/1992 | WO1991002071A3 Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| 05/14/1992 | DE4035877A1 O-glycosylated alpha interferon |
| 05/14/1992 | CA2096016A1 Diagnostic testing for campylobacter jejuni or coli injection using antigens |
| 05/14/1992 | CA2095330A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | CA2095256A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | CA2094916A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/14/1992 | CA2094911A1 Agents and methods for binding to elam-1 |
| 05/14/1992 | CA2094378A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | CA2092075A1 Peptide-based inhibitors of hiv replication |
| 05/14/1992 | CA2055425A1 Polypeptide, dna fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same |
| 05/14/1992 | CA2055146A1 Method for blocking platelet adhesion to collagen |
| 05/13/1992 | EP0485361A1 Pre-S gene codes peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 05/13/1992 | EP0485347A2 Recombinant hepatitis delta antigen, process for the purification and use thereof |
| 05/13/1992 | EP0485209A1 Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides |
| 05/13/1992 | EP0485172A2 Esters and amides of substituted indenyl acetic acids |
| 05/13/1992 | EP0485158A2 Esters and amides of substituted phenyl acetic acids |
| 05/13/1992 | EP0484787A2 HCV-specific peptides, process for obtaining them and their use |
| 05/13/1992 | EP0484621A2 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens |
| 05/13/1992 | EP0484508A1 Proteinaceous fat substitute. |
| 05/13/1992 | EP0484500A1 Recombinant protein which binds to a complex viral antigen of hiv-1 |
| 05/13/1992 | EP0484477A1 Maturation of hemopoietic cells |
| 05/13/1992 | EP0484452A1 Fibulin |
| 05/13/1992 | EP0484440A1 Efficient directional genetic cloning system |
| 05/13/1992 | EP0484416A1 Regulation of nerve growth factor synthesis in the central nervous system |